Skip to Content

When (and How) to Rescue an Underperforming Clinical Trial

Diagnose before you intervene — the single biggest mistake in trial rescues.
August 10, 2026 by

Every clinical operations team has seen a study drift off track: enrollment stalls, data quality slips, or a site relationship deteriorates past the point of informal fixing. The hard part is rarely noticing the problem. It is deciding, objectively, whether the study needs a rescue — and if so, what that rescue should actually involve.

The signals that matter more than a single missed milestone

One missed timeline is not a crisis; most studies miss at least one. What signals a genuine rescue situation is a pattern: enrollment consistently below plan for two or more consecutive periods, a rising query backlog that keeps growing despite added resource, or site relationships where the same issues resurface after being "resolved" multiple times. Rescue decisions should be based on trend, not on a single bad month.

Diagnose before you intervene

The instinct when a study is struggling is to act immediately — add sites, add monitors, replace the CRO. Acting before understanding the actual root cause usually adds cost without fixing the underlying problem. A rescue assessment should start with a structured review: is this a protocol design issue, a site selection issue, a vendor performance issue, or an internal governance issue? Each has a different fix, and they are frequently confused with one another.

Separate the recoverable from the fundamental

Some problems are operational and recoverable with the right intervention: underperforming sites can be replaced, a monitoring cadence can be tightened, a CRO relationship can be restructured. Others are closer to fundamental — a protocol with an enrollment criteria that does not match the available patient population, for example — and no amount of operational fixing will resolve them. An honest rescue assessment tells you which situation you are actually in before you commit further budget to a fix that cannot work.

Build a realistic recovery plan, not an optimistic one

Recovery plans built under pressure to show progress to leadership often assume best-case timelines and full site cooperation. These plans look reassuring in a slide deck and then fail again three months later, which damages credibility further. A realistic plan states its assumptions explicitly, includes contingency for at least one further setback, and is specific about what "on track" will actually look like at each checkpoint.

Communicate the rescue transparently

Sponsors, boards and investors respond far better to a clearly diagnosed problem with a credible plan than to reassurance that turns out to be premature. A rescue assessment carried out by someone with no stake in defending the original plan — internal or external — tends to produce a more credible account, and a more credible plan, than one produced by the team that built the original strategy.

When to bring in an outside assessment

Internal teams closest to a struggling study are often the least able to diagnose it objectively — not from lack of skill, but because they are too close to the decisions that got the study to this point. Our Clinical Trial Consulting service includes study rescue assessments: an independent, senior-led review that identifies the real cause of underperformance and builds a recovery plan grounded in what is actually achievable, not what would be reassuring to hear.

Building a Vendor Oversight Plan for Clinical Trials
The sponsor stays accountable, even when the work is subcontracted.

Get 10% Off Your First Order

Subscribe to our newsletter for clinical research insights and get an instant 10% discount code.

Thanks for subscribing! Use code WELCOME10 at checkout for 10% off your first order.